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Eye induction and eye field separation are the earliest events during vertebrate eye development. Both of these processes occur much earlier
than the formation of optic vesicles. The insulin-like growth factor (IGF) pathway appears to be essential for eye induction, yet it remains unclear
how IGF downstream pathways are involved in eye induction. As a consequence of eye induction, a single eye anlage is specified in the anterior
neural plate. Subsequently, this single eye anlage is divided into two symmetric eye fields in response to Sonic Hedgehog (Shh) secreted from the
prechordal mesoderm. Here, we report that B56ε regulatory subunit of protein phosphatase 2A (PP2A) is involved in Xenopus eye induction and
subsequent eye field separation. We provide evidence that B56ε is required for the IGF/PI3K/Akt pathway and that interfering with the PI3K/Akt
pathway inhibits eye induction. In addition, we show that B56ε regulates the Hedgehog (Hh) pathway during eye field separation. Thus, B56ε is
involved in multiple signaling pathways and plays critical roles during early development.
© 2006 Elsevier Inc. All rights reserved.Keywords: B56ε; PP2A; Eye induction; Eye field separation; IGF; HhIntroduction
Vertebrate eye development starts at gastrulation when the
eye field is specified in the anterior neural plate. Subsequently,
the eye field is divided into two in response to an inhibitory
signal secreted from the prechordal plate. Both eye induction
and eye field separation have already been completed by the
time optic vesicles become morphologically visible (for review,
see Chow and Lang, 2001).
Proper eye development relies on the precise expression of
eye field transcription factors (EFTFs) (Chow and Lang, 2001;
Zuber et al., 2003). Although these genes may be induced
through distinct mechanisms (Oliver et al., 1995; Stoykova et al.,
1996; Zhang et al., 2000), they are expressed largely in an
overlapping pattern. EFTFs are capable of inducing ectopic eye
formation in misexpression experiments. In addition, mutations
in EFTFs cause abnormal eye development. Interestingly,⁎ Corresponding author. Department of Pediatrics, The Ohio State University,
700 Children's Dr., Columbus, OH 43205, USA. Fax: +1 614 722 5892.
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doi:10.1016/j.ydbio.2006.10.011EFTFs regulate the expression of each other (Ashery-Padan
and Gruss, 2001; Bailey et al., 2004; Chow and Lang, 2001).
Several signaling pathways have been found to be essential for
early eye development. These include the IGF pathway (Eivers
et al., 2004; Pera et al., 2003; Pera et al., 2001; Richard-
Parpaillon et al., 2002), the Wnt pathway (Cavodeassi et al.,
2005; Rasmussen et al., 2001; Van Raay et al., 2005), and the
planar cell polarity (PCP) pathway (Lee et al., 2006; Maurus et
al., 2005; Moore et al., 2004). Among these, IGF, a potent neural
and forebrain inducer, is sufficient and necessary for eye
induction. In Xenopus and Zebrafish, ectopic activation of the
IGF pathway induces the expression of EFTFs and highly
organized ectopic eyes. Conversely, interfering with IGF
signaling blocks eye induction (Eivers et al., 2004; Pera et al.,
2003; Pera et al., 2001; Richard-Parpaillon et al., 2002).
Recently, it has been shown that Kermit2, an IGF receptor
binding protein, plays a role during Xenopus eye development
(Wu et al., 2006). Although the function of IGF signaling during
mammalian eye induction has not been studied, several IGF
pathway components are expressed at very high levels in rat
early retina progenitors (James et al., 2004). This suggests that
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as well. In many experimental contexts, IGF activates the PI3K/
Akt and MAPK pathways (Oldham and Hafen, 2003). The
MAPK pathway has been shown to be important for neural
induction (Pera et al., 2003; Pera et al., 2001; Stern, 2005).
However, it remains unclear how IGF downstream pathways are
involved in eye induction.
After eye induction, EFTFs are expressed as a single domain
in the anterior neural plate. In many species, EFTFs expression
domain is subsequently divided into two by Shh secreted from
the prechordal plate (Ekker et al., 1995; Li et al., 1997; Marti
et al., 1995; Shimamura et al., 1995), leading to the formation of
two symmetric eye primordia (Chow and Lang, 2001; Li et al.,
1997). In agreement with the role of Shh in the eye field
separation, cyclopia or holoprosencephaly has been found in:
human patients with reduced Shh signaling (Roessler et al.,
1996; Wallis and Muenke, 2000); mice lacking Shh (Chiang
et al., 1996), Smoothened (Smo) (Zhang et al., 2001), or Dis-
patched (Ma et al., 2002); animals exposed to the Hh inhibitor,
cyclopamine, during embryonic development (Keeler, 1970)
and Xenopus or chick embryos with the prechordal mesoderm
physically removed (Li et al., 1997). Interestingly, Zebrafish eye
field separation process relies more on the medial lateral
movement of retina precursor cells (Woo and Fraser, 1995;
Woo et al., 1995; Rembold et al., 2006). Mutants exhibiting
abnormal cell movement show various degrees of cyclopia
(Hammerschmidt et al., 1996; Heisenberg et al., 1996;
Heisenberg and Nusslein-Volhard, 1997; Marlow et al., 1998;
Solnica-Krezel et al., 1996).
PP2A is one of a serine/threonine protein phosphatases
abundantly expressed and is involved in numerous biological
processes. The PP2A holoenzyme consists of a catalytic subunit
(C), a structural subunit (A), and a regulatory subunit (B). The
activity and specificity of PP2A are regulated by its regulatory
subunits. Three PP2A regulatory subunit families, B55, B56,
and PR72, have been identified (Janssens and Goris, 2001).
Among these, the B56 family (McCright and Virshup, 1995)
comprises the largest regulatory subunit family. Five B56
family members have been identified in mammals, including α,
β, γ, δ, and ε. B56 family members have been implicated in the
canonical Wnt pathway (Gao et al., 2002; Li et al., 2001;
Ratcliffe et al., 2000; Seeling et al., 1999; Yang et al., 2003), the
PCP pathway (Hannus et al., 2002), and are required for cell
survival (Hannus et al., 2002; Li et al., 2002; Silverstein et al.,
2002). Our previous studies have shown that B56ε is required
for the Wnt pathway during Xenopus axis specification and
midbrain–hindbrain boundary formation (Yang et al., 2003).
Here, we report that B56ε is required for the IGF/PI3K/Akt and
the Hh pathways. B56ε is involved in eye induction and eye
field separation during Xenopus development.Materials and methods
Oocyte and embryo manipulations
Xenopus oocytes and embryos were obtained as described (Sive et al., 2000).
Host transfer, regular microinjection, and animal cap assays were performed asdescribed (Yang et al., 2003). For 32-cell stage injection, 5 nl of solution was
injected. The dosage of RNA or morpholino for microinjection was indicated in
the text or figure legend. For experiments in which RNA and morpholino were
injected into the same embryo, RNA and morpholino were injected sequentially.
For LY294002 treatment, animal caps were exposed to various concentrations of
the drug from stage 9 to stage 13.
Plasmid construction and morpholino
FLAG-costal2 was generated by PCR from zebrafish costal2 (Tay et al.,
2005). Gli-VP was constructed by cloning a PCR fragment containing the zinc
finger of Xenopus Gli1 to the pCS2-VP16 vector (GCCACTCGAGAATT-
CTGGCTTGGATACGATTGGG and GGAGCTCGAGTCTAGATC-
CAGCTGGTTTTCCCCTT). Myc-EGFP was constructed by cloning the PCR
fragment of EGFP between the EcoRI and XhoI sites of pCS2-MT (ATAAA-
GAATTCAATGGTGAGCAAGGGCGAGGAG and ATATCTCGAGT-
TACTTGTACAGCTCGTCCATGCC). The morpholino against B56ε (εmor)
and the 5-mismatched control morpholino were described (Yang et al., 2003).
RT-PCR and whole mount in situ hybridization
RNA extraction and RT-PCR method were described previously (Yang
et al., 2003). PCR primers are: sox3 (up): AGCACAGGTATGACATGAGC,
sox3 (down) : ATCATATCTCGCAGGTCTCC; shh (up) : 5 ′ -
TACTGTCTCGTCTCTACACC-3′, shh (down): 5′-CATCTGTCCGAGC-
GAAGC-3′; foxA2 (up): 5′-CCAGCTCCATGAACATGTCC-3′, foxA2
(down): 5′-TCCATAAATTGGGCTCATGG-3′; and ptc-1 (up): 5′-GGACAA-
GAATCGCAGAGCTG-3′, ptc-1 (down): 5′-GGATGCTCAGGGAACCT-
TAC-3′. Primers for dickkopf-1, goosecoid, cerberus, nodal-related3, sizzled,
ODC, otx2 (Yang et al., 2003), rx lhx2, pax6, six3, and ET (Zuber et al.,
2003) were described. Whole mount in situ hybridization was performed as
described (Sive et al., 2000).
Western blots and Co-IP
Western blots were performed as described (Yang et al., 2003). Antibodies
are anti-FLAG (M2, Sigma, 1:1000), anti-Myc (9E10, Sigma, 1:1000), anti-
ERK (Transduction laboratory, 1:2500), anti-p-ERK (Cell Signaling, 1:1000),
anti-Akt (Cell Signaling, 1:1000), and anti-p-Akt (Sigma, 1: 500). For Co-IP,
caps were homogenized in NP-40 buffer (1× PBS, 0.1% NP-40, proteinase
inhibitor cocktail; 10 μl per animal cap). Cleared lysates from a group of 15
animal caps were incubated with antibody (1:100 dilution) at room temperature
for 2 h and further incubated with protein G beads for 1 h. Beads were washed
with NP-40 buffer three times. Samples were boiled in 1× SDS sample buffer for
3 min and separated by SDS-PAGE.Results
Injection of εmor causes dose-dependent eye defects
We have previously reported that depletion of B56ε in the
neural ectoderm impairs midbrain–hindbrain boundary forma-
tion and causes eye defects (Yang et al., 2003). To further
characterize the function of B56ε during Xenopus eye
development, we injected various doses of εmor into two
dorsal animal blastomeres at the 8-cell stage. Injected embryos
were harvested at stage 20 and analyzed by whole mount in situ
hybridization for rx (Mathers et al., 1997) and six3 (Zhou et al.,
2000), two definitive eye markers.
At stage 20, control embryos had two symmetric rx (100%,
n=57) and six3 (100%, n=64) expression domains. However,
embryos injected with 2.5 ng of εmor had either a single rx
(20%, n=104) and six3 (17%, n=86) expression domain, or
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5 ng of εmor caused more severe phenotypes. Virtually all
injected embryos exhibited one rx (n=93) and one six3
(n=112) expression domain. In addition, the expression of rx
(66%) and six3 (57%) in many injected embryos was reduced.
When 7.5 ng of εmor was injected, the majority of injected
embryos completely lacked rx (74%, n=66) and six3 (54%,
n=56) expression (Fig. 1A). Thus, injection of εmor caused
dose-dependent eye defects.
To address the specificity of the εmor, we took advantage of
a control morpholino carrying 5 mismatched nucleotides
(5mis). Injection of εmor (5 ng) caused a nearly complete
blockage of B56ε translation. In contrast, B56ε translation
appeared to be normal when 5 ng of 5mis was injected (Fig.
1B). We noticed that a higher dose of 5mis (20 ng) reduced the
translation of B56ε slightly (not shown). Thus, 5mis only has
minimal effect on B56ε translation.
Next, we injected various doses of εmor and 5mis and
analyzed the effects of morpholino injection on early develop-
ment. Injection of 5 ng of εmor slightly delayed blastopore
closure (not shown). At the tadpole stage, 69% (n=124) of
injected embryos failed to form eyes and developed shorter
anterior–posterior (AP) axis (Fig. 1C). When 7.5 ng of εmor
was injected, all injected embryos had permanent blastopore
closure defects. At the tadpole stage, 86% of injected embryos
(n=107) had severe morphogenesis defects and essentially all
injected embryos lacked eye formation. Injection of 5mis only
caused minimal developmental defects. Embryos injected with
5 ng of 5mis developed normally (n=77, Fig. 1C). When 7.5 ng
of 5mis was injected, all injected embryos had normal
blastopore closure. At the tadpole stage, 7% of embryos
exhibited fused eyes (not shown), 67% of embryos developed
slightly reduced eyes (as shown in Fig. 1C), and the remaining
26% of embryos were normal (n=96). We also analyzed rx and
six3 expression in 5mis injected embryos. Similar to control
embryos, embryos injected with 5 ng of 5mis exhibited two
separate rx (n=41) and six3 (n=46) expression domains at
stage 18 (Fig. 1D). Injection of 7.5 ng of 5mis affected rx and
six3 expression weakly, with 14% of embryos (n=47)
exhibiting fused rx expression domains, and 29% of embryos
(n=48) exhibiting fused six3 expression domains (Fig. 1D).
Thus, injection of mismatched control morpholino only induced
minimal eye defects. Taken together, the above results indicate
that depletion of B56ε by εmor injection affects the expression
of EFTFs and eye development.
In Xenopus, weak ventralization results in cyclopia, or
embryos without eyes (De Robertis and Kuroda, 2004; Harland
and Gerhart, 1997; Heasman, 1997; Kao and Elinson, 1988;
Xanthos et al., 2002). We have previously shown that maternal
depletion of B56ε (by injecting 2.5 to 5 ng of εmor into Xe-
nopus oocyte and following with host transfer procedure)
resulted in ventralized embryos (Yang et al., 2003). To address
whether the eye defects observed in εmor injected embryos are
caused by ventralization, we compared the effects of oocyte
injection (maternal depletion) and 8-cell stage injection on axis
specification. Consistent with our previous observation, injec-
tion of 5 ng of εmor into oocyte resulted in ventralized embryos.When analyzed at early gastrula stage, the expression of
organizer genes was severely reduced. These include dickkopf-1
(Glinka et al., 1998), cerberus (Bouwmeester et al., 1996),
goosecoid (Cho et al., 1991) and nodal-related3 (Smith et al.,
1995). The expression of sizzled (Salic et al., 1997), a ventral
specific gene, was up-regulated. In contrast to maternal
depletion of B56ε, sizzled and organizer genes were expressed
normally in embryos injected with 7.5 ng of εmor at the 8-cell
stage (Fig. 2A). We also analyzed the spatial expression pattern
of chordin (chd) (Sasai et al., 1994), another organizer gene, in
embryos injected with εmor at the 8-cell stage. Compared to
control embryos (n=67), the expression of chd was normal in
all εmor injected embryos (n=83, Fig. 2B). Thus, injection of
εmor at the 8-cell stage impairs the expression of eye markers
without ventralizing embryos.
We also noticed that higher doses of εmor injection caused
blastopore closure defects. It is known that gastrulation defects
may indirectly affect eye development. To address whether
B56ε plays a direct role during eye development, we injected
various doses of εmor into a dorsal animal blastomere (A1),
which later gives rise to the anterior neural ectoderm (Moody,
1987a,b), at the 32-cell stage. Under this condition, injected
embryos did not exhibit blastopore closure defects (not
shown). When analyzed at stage 18, εmor injection resulted
in dose-dependent eye defects, judged by rx expression
(Fig. 2C). Embryos injected with 0.5 ng of εmor expressed
rx relatively normally (90%, n=42). When 1 ng of εmor was
injected, the level of rx expression was normal in 76% of
injected embryos (n=49). However, rx positive cells were
found to be closer to the midline (on the injected side) in 41%
of the embryos. Injection of 1.5 ng of εmor reduced rx
expression in 75% of injected embryos (n=61). Notably, none
of these embryos completely lacked rx expression (not
shown). This is likely because multiple blastomeres of the
32-cell stage embryo contribute to the eye (Moody, 1987b).
Regardless, εmor injection impairs rx expression when
targeted to the anterior neural ectoderm. This demonstrates
that B56ε plays a direct role in the regulation of rx expression.
To better understand how B56ε regulates eye induction, we
further examined whether B56ε depletion affects neural
induction and forebrain specification. Thus, 4.5 ng of εmor
was injected unilaterally at the 8-cell stage. This dose of εmor
injection reduces EFTFs without significantly blocking the
blastopore closure. At stage 12.5, 55% (n=58) of εmor injected
embryos exhibited reduced rx expression on the injected side.
In contrast, εmor injection did not significantly alter the
expression of sox3 (100%, n=82), a pan-neural marker (Penzel
et al., 1997); and otx2 (94%, n=47), a forebrain marker
(Pannese et al., 1995) (Fig. 2D). This indicates that neural
induction and forebrain specification occurred in B56ε depleted
embryos.
We have previously shown that B56ε is required for the Wnt
pathway (Yang et al., 2003). As the Wnt pathway is involved in
the AP patterning, we tested whether the eye defects in B56ε
depleted embryos were caused by abnormal AP patterning
within the developing brain. Thus, markers expressed in
different territories of the brain were analyzed. At stage 14,
Fig. 1. Dose-dependent effects of B56ε depletion on eye development. (A) Whole mount in situ hybridization showing the expression of rx (upper panels) and six3
(lower panels) in stage 20 control embryos, 2.5 ng εmor injected embryos, 5 ng εmor injected embryos, and 7.5 ng εmor injected embryos. εmor was injected into two
dorsal animal blastomeres at the 8-cell stage. (B) Western blot showing the effects of εmor and 5mis on the translation of B56ε-FLAG. Myc-EGFP was used as a
control for injection and loading. Morpholinos (5 ng) were injected into one of the dorsal animal blastomere at the 8-cell stage. Subsequently, a mixture of B56ε
(200 pg) and Myc-EGFP (50 pg) was injected into the same blastomere. Injected embryos were harvested at the late gastrula stage. (C) Whole embryo phenotypes at
the tadpole stage showing the effect of morpholinos injection on early embryonic development. Embryos were either uninjected (top), or bilaterally injected with εmor
(5 ng, middle left; 7.5 ng, lower left), or injected with 5mis (5 ng, middle right; 7.5 ng, lower right) into both dorsal animal blastomeres at the 8-cell stage. (D) Whole
mount in situ hybridization showing the expression of rx (upper panels) and six3 (lower panels) in stage 18 control embryos, 5 ng of 5mis injected embryos, and 7.5 ng
of 5mis injected embryos. 5mis was injected into two dorsal animal blastomeres at the 8-cell stage. Note that less than 30% of embryos injected with 7.5 ng of 5mis
exhibited fused rx or six3 expression at this stage. The rest of embryos were normal (not shown).
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Fig. 2. B56ε plays a direct role in the regulation of rx expression. (A) RT-PCR showing that maternal depletion of B56ε (oocyte injection) reduced the expression of
dorsal specific genes (dickkopf-1, goosecoid, cerberus, and Xenopus nodal related3 (xnr3)) and enhanced the expression of a ventral-specific gene (sizzled) at stage
11. Injection of 7.5 ng of εmor into two dorsal animal blastomeres at the 8-cell stage did not affect the expression of above genes.ODCwas used as the loading control.
(B) Whole mount in situ hybridization showing that the expression of chd in a control embryo and an embryo injected with 7.5 ng of εmor. (C) Whole mount in situ
hybridization showing the expression of rx in a stage 18 uninjected embryo, an embryo injected with 0.5 ng of εmor, an embryo injected with 1 ng of εmor, and an
embryo injected with 1.5 ng of εmor. εmor was injected into one of A1 blastomeres at the 32-cell stage. Lineage tracer, n-β-gal, was co-injected with εmor to indicate
the side of injection. (D) Whole mount in situ hybridization showing the expression of rx (stage 12.5), sox3 (pan-neural, stage 12.5), otx2 (pan-forebrain, stage 12.5),
and pax2 (midbrain, stage 14), arx (diencephalons, stage 14), and eomesodermin (telencephalon, stage 26/27) in control embryos (upper panels) and embryos injected
with εmor (4.5 ng, lower panels). The right side was injected as indicated by the Red-gal staining. Embryos were injected unilaterally at the 8-cell stage.
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expressed normally in 83% of εmor injected embryos (n=47).
The remaining 17% of embryos exhibited weakly reduced pax2
on the injected side. The expression of arx, a diencephalon
marker (Seufert et al., 2005), was reduced by εmor injection in
48% of injected embryos (n=42). When analyzed at stage 26/
27, 53% of εmor injected embryos (n=40) had reduced
expression of eomesodermin, a telencephalon marker (Ryan
et al., 1998), on the injected side (Fig. 2D). The expression of
meis3, a hindbrain and spinal cord marker (Salzberg et al.,
1999), was normal in εmor injected embryos (not shown).
Notably, despite εmor injection reduced some of these brainmarkers to various degrees, we failed to observe any expansion
of posterior markers in εmor injected embryos. Therefore, it is
unlikely that the eye development defects in B56ε depleted
embryos are caused by abnormal AP patterning, although this
data suggests that B56ε may be involved in telencephalon and
diencephalon development.
B56ε is required for the initiation of a subset of EFTFs
EFTFs regulate the expression of each other (Ashery-Padan
and Gruss, 2001; Bailey et al., 2004; Chow and Lang, 2001).
In principle, the loss of EFTFs expression in εmor injected
Fig. 3. B56ε is required for the induction of a subset of EFTFs. (A) Whole mount in situ hybridization showing the expression of rx, lhx2, optx2, six3, and pax6 in
stage 14 uninjected embryos (upper panels) and embryos bilaterally injected with 7.5 ng of εmor (lower panels). (B) RT-PCR showing the expression of rx, lhx2,
pax6, six3, and ET in control embryos, embryos bilaterally injected with 5 ng or 7.5 ng of εmor from stage 10 (the beginning of gastrulation) to stage 15 (mid-
neurula stage). ODC was used as loading control. (C) Whole mount in situ hybridization showing the expression of rx (left column) and lhx2 (right column) in
stage 14 uninjected embryos (upper panels), embryos injected with εmor (7.5 ng, middle panels), and embryos injected with εmor (7.5 ng) and ε-c (100 pg) (lower
panels). Both dorsal animal blastomeres were injected at the 8-cell stage. Morpholino and ε-c were injected sequentially. Note that the expression of rx and lhx2
was partially rescued by ε-c.
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due to the failure of a subset of EFTFs expression within the
eye field. To distinguish between these possibilities, embryos
were bilaterally injected with 7.5 ng of εmor, a dose of εmor
sufficient for a complete blockage of eye development.
Injected embryos were analyzed by whole mount in situ
hybridization and RT-PCR for EFTFs, including rx, lhx2
(Bachy et al., 2001), optx2 (Zuber et al., 1999), six3, pax6,
and ET (Li et al., 1997).
At stage 14, rx, lhx2, optx2, six3, and pax6 were expressed
as a single domain in the developing eye field in control
embryos. Embryos injected with 7.5 ng of εmor, however,
exhibited severely reduced rx (71%, n=97) and lhx2 (82%,
n=45) expression. The expression of optx2 (80%, n=41),
six3 (82%, n=38) and pax6 (75%, n=44) was only moderately
down-regulated (Fig. 3A). This expression profile was further
confirmed by RT-PCR. The expression of rx, lhx2, pax6, andsix3 was initiated at stage 12. At this stage, injection of 5 ng
and 7.5 ng of εmor severely reduced the expression of rx and
lhx2. In contrast, the expression of six3 and pax6 was only
slightly decreased. The expression of ET was not significantly
affected (Fig. 3B).
The reduction of rx and lhx2 by εmor injection is due to the
loss of endogenous B56ε. When εmor was injected alone, 67%
(n=55) and 66% (n=50) of injected embryos failed to express
rx and lhx2, respectively. The expression of rx and lhx2 was
partially rescued in embryos injected with εmor and ε-c RNA, a
modified B56ε construct that lacks the εmor binding sequence
(Yang et al., 2003). Only 33% (n=57) and 39% (n=54) of
injected embryos lacked rx and lhx2 expression, respectively.
The blastopore closure phenotype was not rescued by ε-c RNA
injection (Fig. 3C). Taken together, the above results demon-
strate that B56ε is required for the initiation of a subset of
EFTFs, suggesting a role of B56ε in eye induction.
Fig. 4. B56ε is required for IGF1-induced EFTFs expression. (A) Whole mount
in situ hybridization showing that εmor injection blocked IGF1-induced rx
expression (upper panels), without affecting IGF1-induced otx2 (middle panels)
and sox3 (lower panels) expression in whole embryos (stage 14). IGF1 (2 ng)
was unilaterally injected at the 8-cell stage into either wild-type embryos, or
embryos that were previously injected with 5 ng of εmor. The right side was
injected. (B) RT-PCR showing εmor injection blocked IGF1-induced rx, pax6,
six3, and lhx2 expression, while IGF1-induced otx2 and sox3 expressions
remain unaffected. εmor (10 ng) was injected at the 1-cell stage. IGF1 (2 ng) was
radially injected into the animal pole of each blastomere at the 4-cell stage.
Animal caps were dissected at late blastula stage and harvested at stage 13.
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IGF signaling is important for eye induction (Eivers et al.,
2004; Pera et al., 2001; Richard-Parpaillon et al., 2002). Since
depletion of B56ε blocks the initiation of some EFTFs, we
tested whether B56ε functions downstream of IGF during eye
induction. Thus, we examined if εmor injection blocks IGF1-
induced EFTFs expression in whole embryos and animal caps.
Compared to control embryos, overexpression of IGF1
induced ectopic expression of rx (51%, n=51), otx2 (82%,
n=45), and sox3 (96%, n=52) in whole embryos. Depletion of
B56ε results in a nearly complete blockage of endogenous and
IGF1-induced rx expression (96%, n=47). In contrast, IGF1
still induced ectopic expression of otx2 (74%, n=46) and sox3
(91%, n=46) in εmor injected embryos (Fig. 4A). In animal
caps, IGF1 induced the expression of rx, pax6, lhx2, six3, sox3,
and otx2. Injection of εmor blocked IGF1-induced rx, pax6,
lhx2, and six3, but not sox3 or otx2 (Fig. 4B). These results
demonstrate that B56ε is required for the EFTFs induction
activity of IGF1, but not for the neural and forebrain induction
activity of IGF1.
The PI3K/Akt pathway is required for IGF1-induced EFTFs
expression
IGF activates the PI3K/Akt pathway and the MAPK pathway
in most experimental contexts (Oldham and Hafen, 2003). Since
B56ε is required for IGF1-induced EFTFs expression, we
further investigated whether B56ε is required for IGF1-induced
Akt and MAPK signaling. Activation of the Akt pathway and
the MAPK pathway was determined by monitoring endogenous
Akt phosphorylation (Ser473) and ERK phosphorylation
(Thr183 and Tyr185), respectively.
As shown in Fig. 5A, IGF1-induced ERK phosphorylation
and Akt phosphorylation in animal caps. Injection of εmor
reduced IGF1-induced Akt phosphorylation, but had no effect
on IGF1-induced ERK phosphorylation, indicating that B56ε is
required for the PI3K/Akt pathway, but not the MAPK pathway.
To determine at which level B56ε functions in the PI3K/Akt
pathway, we tested if B56ε is required for Akt phosphorylation
induced by P110⁎, a constitutively active PI3K (Carballada
et al., 2001). Overexpression of P110⁎ induced Akt phosphor-
ylation in animal caps. P110⁎-induced Akt phosphorylation was
not sensitive to εmor injection, demonstrating that B56ε is
required for the PI3K/Akt pathway upstream of, or at the
parallel level of, PI3K.
The observations that B56ε is required for eye induction and
PI3K/Akt signaling immediately suggest that the PI3K/Akt
pathway is essential for eye induction. To address this, we
examined whether the PI3K/Akt pathway is required for IGF1-
induced EFTFs expression in animal caps and whole embryos.
As expected, overexpression of IGF1 in animal caps induced
rx, pax6, lhx2, six3, otx2, and sox3. Addition of 2.5 nM of
LY294002, a chemical PI3K inhibitor, reduced the IGF1-
induced EFTFs expression without affecting the expression of
otx2 and sox3 (Fig. 5B). Similarly, overexpression of IGF1
induced ectopic expression of rx (49%, n=41), otx2 (62%,n=55), and sox3 (96%, n=52) in whole embryos. Co-injection
of IGF1 with Δp85, a dominant negative regulatory subunit of
PI3K (Carballada et al., 2001), or a kinase dead Akt (dnAkt)
severely blocked IGF1-induced rx expression (76%, n=41 and
90%, n=41, respectively). Notably, Δp85 and dnAkt not only
reduced IGF1-induced rx, but also blocked endogenous rx.
Consistent with the results from the animal cap assay, ectopic
otx2 expression was detected in 61% (n=44) of embryos
injected with IGF1 and Δp85, and in 60% (n=40) of embryos
injected with IGF1 and dnAkt. IGF1 still induced ectopic sox3
Fig. 5. The PI3K/Akt pathway is required for IGF1-induced EFTFs. (A) Western blot showing that εmor injection blocked Akt phosphorylation induced by IGF1, but
had no effect on Akt phosphorylation induced by P110⁎. In addition, εmor had no effect on IGF1-induced ERK phosphorylation. εmor (10 ng) and RNA encoding
IGF1 (2 ng) or P110⁎ (1 ng) were injected sequentially, with εmor being injected at the 1-cell stage and RNAs being injected at the 4-cell stage. Animal caps were
dissected at stage 8/9 and harvested at stage 13. (B) RT-PCR results showing LY294002, a PI3K inhibitor, blocked IGF1-induced expression of rx, lhx2, pax6, and
six3, without affecting IGF1-induced otx2 and sox3 expressions in animal cap assay. IGF1 was injected as described above. Caps were dissected at late blastula stage
and harvested at stage 13. Some caps were exposed to LY294002 from stage 9. (C) Δp85 (2 ng) and dnAkt (2 ng) blocked IGF1 (2 ng) induced rx (upper panels), but
not IGF1-induced otx2 (middle panels) and sox3 (lower panels) in whole embryos. One of the dorsal animal blastomeres was injected at the 8-cell stage. The right side
was injected.
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94%, n=52, respectively. Fig. 5C). Taken together, these results
indicate that PI3K/Akt signaling is required for the EFTFs
induction activity of IGF1.
The PI3K/Akt pathway is required for endogenous eye
induction
Δp85 and dnAkt blocked endogenous rx expression,
suggesting that PI3K/Akt signaling is required for endogenous
eye induction. However, it has been reported that interfering
with the PI3K/Akt pathway impairs mesoderm formation
(Carballada et al., 2001), which may indirectly affect eye
development. To investigate the direct effect of PI3K/Akt
inhibition on eye induction, we injected Δp85 and dnAkt into
dorsal animal blastomeres at the 8-cell stage. Only embryos
without blastopore closure defects were analyzed. Unlike
control tadpoles, which formed two normal eyes (n=49),Δp85 (65%, n=63) and dnAkt (74%, n=84) injected embryos
either lacked eyes completely, or had two severely reduced eyes
located laterally (Fig. 6A). When analyzed at the late gastrula
stage (stage 13), Δp85 injected embryos exhibited reduced rx
(55%, n=49) and lhx2 (57%, n=46) expression. Injection of
dnAkt blocked rx (63%, n=62) and (52%, n=57) lhx2 as well
(Fig. 6B).
Furthermore, we injectedΔp85 and dnAkt into one of the A1
blastomeres at the 32-cell stage. At the tadpole stage, embryos
injected with Δp85 and dnAkt had reduced eyes on the injected
side (53%, n=118 and 46%, n=79, respectively; Fig. 6C). We
also analyzed the expression of rx, myoD (muscle), otx2, and
sox3 when injected embryos reached late gastrula stage.
Injection of Δp85 caused cell-autonomous reduction of rx
expression in 64% of embryos (n=45). These embryos had
normal myoD expression on the injected side, indicating
reduced rx expression was not caused by mesoderm defects.
Injection of dnAkt had similar effects, with 58% of embryos
Fig. 6. The PI3K/Akt pathway is required for eye induction. (A) Injection ofΔp85 (2 ng) or dnAkt (2 ng) into dorsal animal blastomeres at the 8-cell stage blocked eye
formation. (B)Δp85 and dnAkt blocked the expression of rx (upper panels) and lhx2 (lower panels) at stage 14. (C) Injection of Δp85 or dnAkt into A1 blastomere at
the 32-cell stage impaired eye formation on the injected side (left) when embryos reached tadpole stage. Left side was injected. (D) Injection of Δp85 (middle panels)
or dnAkt (lower panels) into A1 blastomere at the 32-cell stage reduced the expression of rx, but not myoD, otx2, and sox3. n-β-gal was used as a lineage tracer.
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sion was normal. The expression of otx2 was not significantly
affected by the injection of Δp85 (100%, n=40) or dnAkt
(96%, n=45). In addition, injection of Δp85 (n=41) or dnAkt
(n=55) did not alter the expression of sox3 (Fig. 6D). Thus,
interfering with the PI3K/Akt pathway can block eye induction
without affecting mesoderm or neural/forebrain induction.
Taken together, the above results indicate that the PI3K/Akt
pathway is required for eye induction.B56ε is required for eye field separation
While higher doses of εmor injection impairs eye induction,
we noticed that embryos injected with lower doses of εmor
formed cyclopic eyes. To further investigate the function of
B56ε during eye field separation, we injected 3.5 ng of εmor
into embryos. Under this condition, the majority of injected
embryos developed cyclopic eyes. To determine whether the
eye field separation defect in εmor injected embryos is due to
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phenotype in εmor injected embryos. Unlike control embryos,
which formed two symmetric eyes (100%, n=57), 75% of εmor
injected embryos (n=64) only formed one eye. In contrast, only
30% of embryos injected with ε-c and εmor were cyclopic
(n=68, Fig. 7A). When analyzed at stage 18, control embryos
developed two bilaterally located rx (n=47) and six3 (n=50)
expression domains. In εmor injected embryos, however, only
one expression domain of rx (69%, n=59) and six3 (66%,
n=60) was observed. ε-c partially rescued this phenotype, with
57% of injected embryos having two rx expression domains
(n=57) and 59% of embryos having two six3 expression
domains (n=58) (Fig. 7B). Therefore, we conclude that B56ε is
required for eye field separation.
B56ε is required for Hh target gene expression during
development
Shh signaling is essential for eye field separation. Since
B56ε is required for eye field separation, we analyzed theFig. 7. B56ε is required for eye field separation. (A) Dorsal (left column) and
lateral (right column) views of an uninjected embryo (upper panels), an embryo
injected with εmor (3.5 ng) (middle panels), and an embryo injected with εmor
and ε-c (100 pg) (lower panel). (B) The expression of rx (upper panels) and six3
(lower panels) in stage 18 control embryos (left column), embryos injected with
εmor (middle column), and embryos injected with εmor and ε-c (right column).
Embryos were bilaterally injected at the 8-cell stage.expression of several Hh target genes in εmor injected embryos.
These include foxA2 (previously known as hnf3β, (Ruiz i
Altaba et al., 1993; Suri et al., 2004)), a floor plate marker; shh,
a notochord and floor plate marker (Ekker et al., 1995); and ptc-
1 and ptc-2 (Koebernick et al., 2001; Takabatake et al., 2000),
Hh receptors that are directly regulated by Hh signaling
(Alexandre et al., 1996).
At stage 14/15, shh was expressed in the dorsal midline of
control embryos (97%, n=38). The expression of ptc-1 was
found broadly in the anterior neural ectoderm and adjacent non-
neural ectoderm (100%, n=38). εmor injected embryos,
however, had no detectable shh expression (50%, n=46) or
ptc-1 expression (83%, n=41). Expression of shh (78%,
n=45) and ptc-1 (66%, n=41) was partially rescued by ε-c
RNA injection (Fig. 8A). Interestingly, shh, ptc-1, and foxA2
were initiated normally, but they were reduced in εmor injected
embryos at late gastrula/early neurula stages (Fig. 8B). As the
expression of Hh target genes is weak during early stages, we
also analyzed Hh target gene expression at tadpole stage.
Compared to control embryos, εmor injected tadpoles exhibited
reduced foxA2 (58%, n=43), ptc-1 (45%, n=44), ptc-2 (49%,
n=43) and shh (58%, n=45) expression (Fig. 8C). Thus,
B56ε is required for Hh target gene expression.
B56ε is required for the Hh pathway
In many species, eye field separation is regulated by Shh-
mediated inhibition of EFTFs expression in the midline. Similar
to the phenotypes observed in εmor injected embryos, mice
embryos deficient in shh develop cyclopia and have reduced Hh
target gene expression (Zhang et al., 2001). It is possible that the
eye field separation defect in εmor injected embryos is caused
by reduced shh transcription. To address this, we overexpressed
Shh in B56ε depleted embryos and asked whether over-
expressed Shh could repress EFTF expression in the midline,
i.e. rescue eye field separation.
At stage 18, two completely separate rx expression domains
were found in control embryos (100%, n=33). Consistent with
our previous results, εmor injected embryos had only one rx
expression domain (63%, n=58). When shh RNAwas injected,
rx expression was markedly reduced (100%, n=43), indicating
that overexpressed Shh was sufficient for suppressing EFTF
expression. Strikingly, only 54% of embryos injected with shh
and εmor (n=56) exhibited reduced rx expression. The pattern
of rx expression in the rest of the embryos (46%) was similar
to that in εmor injected embryos. This result suggests that
B56ε is required for embryos to respond to Hh signaling. To
directly test this hypothesis, we examined whether Shh could
induce ptc-1, a direct target of the Hh pathway (Alexandre
et al., 1996), in B56ε depleted embryos at stage 14. Compared
to control embryos (100%, n=32), εmor injected embryos
exhibited reduced ptc-1 expression (57%, n=56). Injection of
shh resulted in massive ectopic ptc-1 expression (100%,
n=54). In contrast, overexpression of Shh in εmor injected
embryos failed to induce ptc-1 expression (51%, n=63)
(Fig. 9A). These results indicate that B56ε may be involved
the Hh pathway.
Fig. 8. B56ε is required for the expression of endogenous Hh target genes. (A)
Whole mount in situ hybridization showing the expression of shh (upper panels)
and ptc-1 (lower panels) was reduced by εmor (3.5 ng) injection at stage 14/15.
The reduced shh and ptc-1 expression was partially rescued in embryos injected
with εmor and ε-c (100 pg). (B) RT-PCR showing εmor (3.5 ng) injection
reduced ptc-1, foxA2, and shh expression from late gastrula stage. ODC was the
loading control. (C) The expression of ptc-1, ptc-2, foxA2, and shh in tadpole
stage control embryos (left column) and embryos injected with 3.5 ng of εmor
(right column). Embryos were bilaterally injected at the 8-cell stage.
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(Hammerschmidt et al., 1997; Huangfu and Anderson, 2006;
Ingham and McMahon, 2001; McMahon et al., 2003). In
Drosophila, Hh-dependent transcription is mediated by the zinc
finger transcription factor Cubitus interruptus (Ci). In the
absence of an upstream signal, Ci is associated with Costal2(Cos2) and is phosphorylated by several protein kinases within
the Cos2 complex. Phosphorylated Ci undergoes proteolytic
processing, leading to the formation of a repressor form of Ci
(CiR) (Aza-Blanc et al., 1997). Upon binding to Ptc, Hh
activates Smoothened (Smo), a seven-transmembrane protein,
and dissociates Ci from the Cos2 complex (Zhang et al., 2005).
This results in Ci stabilization and ultimately activates the
transcription of Hh targets. Although three Ci homologues,
Gli1, Gli2, and Gli3, have been identified in vertebrates, only
Gli3 undergoes pathway regulated proteolytic processing. It is
generally believed that the vertebrate Hh pathway is operated
similarly in Drosophila and vertebrates.
To further investigate the function of B56ε in the Hh
pathway, we examined whether B56ε is required for Hh target
gene expression induced by Shh (Ekker et al., 1995), oncogenic
SmoM2 (Koebernick et al., 2003), or Gli1 (Ruiz i Altaba,
1999). As expected, Shh, SmoM2, and Gli1 (when over-
expressed with Chd) induced ptc-1 and foxA2 expression in
animal caps. Expression of ptc-1 and foxA2 induced by Shh and
SmoM2 was severely reduced by εmor injection. Depletion of
B56ε slightly inhibited Gli1-induced ptc-1 and foxA2 expres-
sion (Fig. 9B). To better visualize the effect of B56ε depletion
on Gli1 activity, we used non-neuralized animal caps, which
have a lower level of background ptc-1 expression. Injection of
gli1 RNA induced ptc-1 expression. Gli1-induced ptc-1
expression was clearly reduced by εmor injection (Fig. 9C).
In addition, we generated a constitutively active Gli1 (Gli-VP),
which contains the DNA binding domain of Gli1 and the
transcriptional activation domain of VP16. Overexpression of
Gli-VP induced ptc-1 expression in caps dose-dependently. The
activity of Gli-VP was not sensitive to B56ε depletion
(Fig. 9C). Therefore, these results further demonstrate that
B56ε is required the Hh pathway and indicate that B56ε, likely,
regulates the Hh pathway at the level of Gli.
To better understand the mechanism by which B56ε
regulates the Hh pathway, we used two independent assays to
test whether the Hh pathway upstream of Gli remains intact
when B56ε is depleted. The first assay takes advantage of the
observation that Gli3 undergoes proteolytic processing, which
is inhibited by Shh (Wang et al., 2000). Overexpression of myc-
tagged Gli3 (Ruiz i Altaba, 1999) in animal caps resulted in the
expression of both full-length and truncated forms of Gli3. The
truncated Gli3 was not detected when Shh was overexpressed,
indicating Shh inhibited Gli3 processing. Injection of εmor did
not block Shh-dependent Gli3 stabilization (Fig. 9D), demon-
strating that the pathway required for Gli3 stabilization remains
functional when B56ε is depleted. The second assay examines
the interaction between Cos2 and Gli1, which is also negatively
regulated by Shh. When FLAG-Cos2 and myc-Gli1 were co-
expressed in animal caps, FLAG-Cos2 was pulled down by
anti-myc antibody, indicating Cos2 was associated with Gli1
(Tay et al., 2005). Similar to what has been observed in Dro-
sophila (Zhang et al., 2005), overexpression of Shh signifi-
cantly reduced the amount of Cos2 associated with Gli1.
Although εmor injection inhibited target gene expression
induced by Shh, Shh still dissociated the Cos2/Gli1 complex
efficiently in εmor injected caps (Fig. 9E). Therefore, the Hh
Fig. 9. B56ε is required for the Hh pathway. (A) Whole mount in situ hybridization showing εmor (3.5 ng) injection blocked Shh (1 ng)-induced rx reduction (upper
panels) and ptc-1 expression (lower panels) in whole embryos. Embryos were bilaterally injected at the 8-cell stage. (B) RT-PCR showing εmor (10 ng) injection
blocked ptc-1 and foxA2 induced by shh (1 ng), smo-M2 (2.5 ng), and gli1 (0.5 ng) in neuralized animal caps. εmor and RNAs were injected sequentially at the 1-cell
stage. Animal caps were dissected at stage 8/9 and harvested at stage 14. (C) RT-PCR showing εmor injection (10 ng) blocked ptc-1 expression induced by wild-type
Gli1 (500 pg), but not by Gli-VP (50 pg and 100 pg). Embryos were injected and manipulated as described above. (D) Western blot showing overexpression of Shh
inhibited the processing of overexpressed Myc-Gli3 (0.5 ng) in animal caps. The effect of Shh (1 ng) on Myc-Gli3 processing was not affected by εmor (10 ng)
injection. Embryos were injected and manipulated as described above, except that caps were harvested at stage 12. (E) Co-IP results showing overexpression of Shh
(1 ng) dissociated complex formation between FLAG-Cos2 (1 ng) and Myc-Gli1 (1 ng) in animal caps. Injection of εmor (10 ng) did not affect this complex
dissociation induced by Shh. Embryos were injected and manipulated as described above. (F) Whole mount in situ hybridization showing the expression of rx in (from
left to right) a control embryo, an embryo injected with εmor (3.5 ng), an embryo injected with Gli-VP (100 pg), and an embryo injected with Gli-VP and εmor.
Embryos were bilaterally injected at the 8-cell stage.
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embryos.
Above results demonstrate that B56ε is required for the Hh
pathway. To address whether the defective eye field separation
in εmor injected embryo is, indeed, caused by impaired Hh
signaling, we asked whether Gli-VP could repress EFTF
expression in the midline of εmor injected embryos. Thus,
embryos were bilaterally injected with Gli-VP, εmor, or Gli-VP/
εmor. Control and injected embryos were harvested at stage 20
and analyzed for rx expression.
Injection of Gli-VP RNA severely reduced rx expression,
with 27% of embryo lacking rx expression completely and 73%
of embryos exhibiting two faint rx expression domains (n=44).
Consistent with previous results, 87% of εmor injected embryos
exhibited a single rx expression domain (n=33). When Gli-VP
was expressed in embryos injected with εmor, 73% of embryos
exhibited two bilateral rx expression domains (although the
level of rx expression was clearly reduced) and 27% of embryos
lacked detectable rx expression (n=48) (Fig. 9F). Thus, Gli-VP
was capable of suppressing EFTF expression in the midline of
εmor injected embryos, indicating that the eye separation defect
in B56ε depleted embryos is caused by impaired Hh signaling.
Discussion
Our results indicate that B56ε is a component shared by
multiple signaling pathways. We have previously shown that
B56ε is involved in the Wnt pathway (Yang et al., 2003). Wdb,
the Drosophila homologue of B56ε, regulates the PCP pathway
(Hannus et al., 2002). In this paper, we report that B56ε is
required for the IGF/PI3K/Akt and the Hh pathways. Consistent
with its roles in multiple signaling pathways, B56ε is expressed
throughout the neural ectoderm (Yang et al., 2003) and regulates
several processes during neural development. Depletion of
B56ε in the neural ectoderm impairs the midbrain–hindbrain
boundary formation, eye induction, eye field separation, and
floor plate specific gene expression. It appears that different
levels of B56ε are required for these developmental processes.
Partial depletion of B56ε by injecting a lower dose of εmor
blocks midbrain–hindbrain boundary formation, eye field
separation, and floor plate specification, whereas eye induction
defects occur only when the depletion of B56ε is more
complete.
B56ε plays a direct role during eye induction
As a specialized extension of the anterior neural tissue, eye
induction relies on proper axis specification, gastrulation, neural
induction, forebrain induction, and regionalization within the
forebrain. Any perturbation affecting these developmental
processes will impair eye induction. Does B56ε regulate eye
induction directly?
We have previously shown that depletion of maternal B56ε
ventralizes embryos (Yang et al., 2003). When embryos were
injected with εmor at the 8-cell stage, however, axis specifica-
tion, neural induction, and forebrain specification occurred
properly, as judged by the normal expression of dorsal ventralspecific genes, a pan-neural marker, and a pan-forebrain marker.
Similar to our results, it has been reported that injection of a
dominant negative frizzled7 or antisense oligos against wnt11,
FRL1, or X.EXT1 into oocytes, but not fertilized embryos,
causes ventralization (Sumanas et al., 2000; Tao et al., 2005).
This is likely because axis specification occurs shortly after
fertilization. Interfering with Wnt signaling early during
development, as opposed to later, ventralizes embryos (Darken
andWilson, 2001; Yang et al., 2002). As injection of εmor at the
8-cell stage does not ventralize embryos, eye development
defects in B56ε depleted embryos were not caused by
ventralization.
Injection of higher doses of εmor impairs blastopore closure.
This phenotype is likely a consequence of the loss of B56ε,
because embryos injected with the control morpholino had no
gastrulation defects. While gastrulation defects certainly affect
eye development to some degree, we found that the impaired eye
development and the gastrulation defect observed in εmor
injected embryos could be uncoupled. For example, when lower
doses of εmor (2.5 ng–4.5 ng) was injected, or when εmor was
injected at the 32-cell stage, embryos exhibited abnormal EFTFs
expression and defective eye development without having
gastrulation defect. These results demonstrate a direct role of
B56ε in regulation of EFTFs expression and eye development.
Our data argues that depletion of B56ε does not block the
eye field specification per se. Depletion of B56ε had differential
effects on individual EFTFs during the eye induction phase.
While injection of εmor severely blocked the initiation of rx and
lhx2, the expression of six3, pax6 and ETwere only moderately
reduced. These observations demonstrate that the eye field
specification occurred in B56ε depleted embryos. In agreement
with this interpretation, we failed to detect any expansion of
posterior markers, despite observing a reduction in some of the
regional brain markers (arx, emoesodermin, and pax2),
suggesting a yet unknown role of B56ε in brain patterning.
As development proceeds, the eye defects became more severe.
Embryos substantially lost six3 expression, which was only
slightly reduced during earlier stages. Given that EFTFs
regulate each other (Bailey et al., 2004; Chow and Lang,
2001; Mathers and Jamrich, 2000; Zuber et al., 2003), it is likely
that B56ε depleted embryos lost six3 expression during later
stages, because the expression of rx and lhx2 was down-
regulated. Taken together, our results indicate that B56ε is
involved in the initiation of a subset of EFTFs during eye
induction.
Signaling pathway(s) mediated by B56ε during eye induction
Several signaling pathways are involved in early eye
development. These include the IGF pathway (Eivers et al.,
2004; Pera et al., 2003; Pera et al., 2001; Richard-Parpaillon
et al., 2002), the Wnt pathway (Cavodeassi et al., 2005; Esteve
et al., 2004; Maurus et al., 2005; Rasmussen et al., 2001; Van
Raay et al., 2005), and the PCP pathway (Cavodeassi et al.,
2005; Lee et al., 2006; Moore et al., 2004). Among these, IGF1
is a potent neural and forebrain inducer and induces EFTFs
expression efficiently in Xenopus and Zebrafish embryos
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Parpaillon et al., 2002). IGF activates both the MAPK and the
PI3K/Akt pathways in most experimental settings (Oldham and
Hafen, 2003). In particular, IGF/MAPK signaling has been
implicated in neural induction (Kuroda et al., 2005; Linker and
Stern, 2004; Pera et al., 2003). It remains unclear how IGF
downstream pathways regulate eye development.
We provide evidence that B56ε regulates PI3K/Akt signaling
downstream of IGF. Depletion of B56ε blocked IGF1-induced
Akt phosphorylation, but had no effect on MAPK phosphor-
ylation. Moreover, P110⁎-induced Akt phosphorylation was not
sensitive to B56ε depletion. This is consistent with a recent
study, showing that B56 family members are required for Akt
phosphorylation in PC12 cells (Van Kanegan et al., 2005), and
suggests that B56ε is required for the PI3K/Akt pathway
upstream of, or at the parallel level of, PI3K.
In addition, our data demonstrates that the PI3K/Akt
pathway is essential for eye induction. In agreement with this
view, ectopic EFTFs expression induced by IGF1 was blocked
by Δp85 or dnAkt in whole embryos. In animal caps, IGF1-
induced EFTFs expression was inhibited by LY294002, a PI3K
inhibitor. Moreover, interfering with the PI3K/Akt pathway
impaired endogenous EFTFs expression and blocked eye
formation. Notably, in all these experimental settings, neural
or forebrain markers (sox3 and otx2) were expressed normally.
Thus, while it appears that IGF/MAPK signaling functions in
neural induction, the IGF/PI3K/Akt pathway (maybe together
with other pathways) is involved in eye induction. Thus, for the
first time, we show that the IGF/PI3K/Akt pathway is essential
for eye induction. Further experiments are needed to better
understand the detailed mechanism through which PI3K/Akt
pathway regulates eye induction.
To our surprise, overexpression of ca-Akt or P110⁎ did not
significantly rescue rx expression in εmor injected embryos
(not shown). This may indicate that B56εmediates multiple eye
induction signaling pathways. While overexpression of ca-Akt
or P110⁎ restores Akt signaling, other B56ε-dependent eye
induction pathways may still be inhibited in B56ε depleted
embryos. What may be other B56ε-dependent eye induction
pathways? As a Dishevelled interacting protein (Ratcliffe et al.,
2000), B56ε is required for the canonical Wnt pathway in Xe-
nopus (Yang et al., 2003). Its homologue, Wdb, is involved in
the PCP pathway in Drosophila and regulates convergent
extension during Zebrafish development (Hannus et al., 2002).
Both the Wnt and the PCP pathways are important for eye
development. The canonical Wnt pathway seems to play dual
roles during eye development. Wnt signaling promotes the
proliferation of retina progenitor cells within the eye field and
expands the retina progenitor cell lineage through sox2 (Van
Raay et al., 2005). Under certain conditions, activation of the
canonical Wnt pathway induces ectopic eyes (Rasmussen et al.,
2001), likely through stimulating retina progenitor cell
proliferation. During eye induction, however, Wnt signaling
caudalizes the forebrain and antagonizes eye field specification
(Cavodeassi et al., 2005; Esteve et al., 2004). Therefore, it is
unlikely that the B56ε-dependent canonical Wnt pathway
activates the expression of EFTFs during eye induction.Interestingly, embryos injected with a higher dose of εmor,
exhibited severe blastopore closure defects, a typical PCP
related phenotype. This suggests that Xenopus B56ε, like its
Drosophila homologue Wdb, may be involved in the PCP
pathway as well. Contrary to the inhibitory effect of the
canonical Wnt pathway on eye induction, the PCP pathway is
required for eye induction. In Zebrafish, Wnt11 signaling
antagonizes canonical Wnt signaling and promotes eye field
specification within the forebrain. It also regulates morphogen-
esis within the nascent eye field (Cavodeassi et al., 2005).
Similarly, the PCP pathway regulates eye field specification and
the cell movement within the eye field in Xenopus (Lee et al.,
2006; Maurus et al., 2005). Thus, it is possible that B56ε
mediates both the PI3K/Akt and the PCP pathways during eye
induction. Further experiments will be needed to determine
whether B56ε is indeed a key player of the PCP pathway in
Xenopus and whether B56ε regulates both the PI3K/Akt and the
PCP pathways during eye induction.
B56ε mediates the Hh pathway during eye field separation
Depletion of B56ε impairs eye field separation. Our results
indicate that the defective eye separation in B56ε depleted
embryos is caused by the abnormal Hh signaling. We observed
that εmor injected embryos not only developed cyclopic eyes,
but also lost the expression of Hh target genes, including shh,
ptc-1, ptc-2, and foxA2. In addition, B56ε depleted embryos
could not respond to overexpressed Shh. The activities of Shh,
Smo, and the wild-type Gli1 were B56ε-dependent, while
constitutively active Gli1 (Gli-VP) bypassed the requirement of
B56ε. This epistasis analysis suggests that B56ε regulates the
Hh pathway at the level of Gli. In agreement with this
interpretation, although B56ε depletion blocked Shh-induced
target gene expression, the Hh pathway upstream of Gli
appeared to remain intact in B56ε depleted embryos, as judged
by results from Gli3 processing and Gli1/Cos2 complex
dissociation assays. Importantly, when Hh signaling in B56ε
depleted embryos was restored by overexpression of Gli-VP, the
midline expression of rx was suppressed. Thus, B56ε mediates
the Hh pathway during the eye field separation.
Interestingly, we found that depletion of B56ε has no effect
on Gli1 nuclear translocation. In addition, the activity of a Gli1
mutant deficient for Sufu binding (Dunaeva et al., 2003) is still
sensitive to B56ε depletion (data not shown). It will be of
interest to test if B56ε regulates the DNA binding affinity of Gli
protein or the interaction between Gli and transcriptional co-
activators. PP2A has been implicated in the Hh pathway
(Krishnan et al., 1997). As a regulatory subunit of PP2A, B56ε
may regulate Gli phosphorylation. In Drosophila, Ci phosphor-
ylation appears to be critical not only for Ci processing, but also
for the formation or the function of Ci activator. The activity of
an uncleavable Ci is still under the control of PKA (Wang et al.,
1999). Similarly, Gli1, which does not undergo pathway
regulated proteolytic processing, can be inhibited by PKA
(Lee et al., 1997). While this work was in the final stage of
preparation, Wdb, the Drosophila B56ε orthologue, was
identified from a genome-wide screen for Hh pathway
491A.M. Rorick et al. / Developmental Biology 302 (2007) 477–493components (Nybakken et al., 2005). Therefore, understanding
how B56ε modulates the Hh pathway will likely uncover an
important mechanism for Ci/Gli regulation.
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